Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life
about
[Osler's disease].Cerebral and spinal vascular involvement in Hereditary Hemorrhagic Telengiectasia: Report of two casesNovel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and plateletsNeurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations.Neurovascular radiosurgery.Hereditary Haemorrhagic Telangiectasia Cerebrospinal Localization in Adults and Children. Review of 39 cases.Endoglin is required in Pax3-derived cells for embryonic blood vessel formation.Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessmentHereditary hemorrhagic telangiectasia.Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls.Hereditary haemorrhagic telangiectasia in children. Endovascular treatment of neurovascular malformations. Results in 31 patients.Early neonatal complications from pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: case report and review of the literature.Screening for arteriovenous malformations in hereditary haemorrhagic telangiectasia.Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia.Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician.
P2860
Q30701389-9B8BAF93-9039-479C-9BC0-98626CD8C171Q34561097-E459F466-3692-4EC6-9E1E-F3A3F8B8EEC4Q35092843-12377C92-ED77-4112-9985-F61DBE20CB41Q35106314-66081059-2BB8-4B69-93C7-EC96F7DF2811Q35613217-3449F70F-EB30-4826-A2E4-3CE2F4F7EF07Q35966851-382818CC-3622-4BF8-8622-F647DE52CC3EQ36294968-9C4DBC3F-56C4-4137-827F-86692CD161FAQ36395997-5891A348-FEAB-4003-9583-6DF59F6E0865Q37055681-4D80481E-CB63-41D9-B6F1-DF1638315BF3Q37151345-333CAA96-648D-4DEC-9BF1-D01988796DA3Q37479646-C50323CA-4F47-4A59-AA66-226DF7FB6287Q37768248-A6CBE96B-3C52-4263-A91B-A736499B1910Q37944287-52FB86EA-DC41-4F44-A715-F7139CDBB62EQ38885656-A8E6638A-7C1B-45F8-B3CE-B6BEE2A6A952Q43146590-ABD0C3AC-AAC8-4FAE-A803-199B1B0BEF4DQ46704794-0790FA2C-58F0-4CDC-A4C6-D6718C119A53Q48536100-523AA58E-CE42-43E5-AE7B-FF6B604A0549
P2860
Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Should asymptomatic patients w ...... ,061 years of HHT patient life
@ast
Should asymptomatic patients w ...... ,061 years of HHT patient life
@en
type
label
Should asymptomatic patients w ...... ,061 years of HHT patient life
@ast
Should asymptomatic patients w ...... ,061 years of HHT patient life
@en
prefLabel
Should asymptomatic patients w ...... ,061 years of HHT patient life
@ast
Should asymptomatic patients w ...... ,061 years of HHT patient life
@en
P2093
P2860
P356
P1476
Should asymptomatic patients w ...... ,061 years of HHT patient life
@en
P2093
P2860
P304
P356
10.1136/JNNP.74.6.743
P407
P577
2003-06-01T00:00:00Z